MYC and inflammatory bowel disease: Interestingly, Qu et al.'s study showed that inflammation, characterized by IBD, upregulated key glycolytic enzyme expression via activation of STAT3/c-myc signaling pathway within dextran sulfate sodium- (DSS-) induced mouse colitis model [11], indicating cell metabolism has been reprogramed during the process from IBD to CRC.